^
    Apply
    Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms (NCT05656248)
    Phase 2
    St. Jude Children's Research Hospital
    Recruiting
    Last update posted :
    02/14/2025
    Initiation :
    01/17/2023
    Primary completion :
    08/01/2025
    Completion :
    08/01/2028
    TP53 • NF1 • RUNX1 • ETV6 • CEBPA • CD4 • MECOM • GATA2 • ANKRD26
    |
    Vyxeos (cytarabine/daunorubicin liposomal formulation)
    Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma (NCT01745588)
    Phase 2
    Memorial Sloan Kettering Cancer Center
    Active, not recruiting
    Last update posted :
    07/03/2024
    Initiation :
    12/01/2012
    Primary completion :
    12/01/2025
    Completion :
    12/01/2025
    CD34
    |
    dexamethasone • pomalidomide
    Dexamethasone and Robotic-assisted Hysterectomy (NCT04762381)
    Phase N/A
    Herning Hospital
    Completed
    Last update posted :
    06/04/2024
    Initiation :
    06/01/2022
    Primary completion :
    02/06/2024
    Completion :
    02/06/2024
    IL6 • CRP
    |
    dexamethasone
    Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT) (NCT05405387)
    Phase 2
    University of Utah
    Recruiting
    Last update posted :
    02/13/2024
    Initiation :
    02/09/2023
    Primary completion :
    02/01/2025
    Completion :
    02/01/2027
    CD34
    Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM (HO147SMM) (NCT03673826)
    Phase 2
    Stichting Hemato-Oncologie voor Volwassenen Ned...
    Active, not recruiting
    Last update posted :
    11/01/2023
    Initiation :
    11/19/2018
    Primary completion :
    08/01/2024
    Completion :
    12/01/2028
    PTPRC • NCAM1
    |
    lenalidomide • carfilzomib • dexamethasone
    UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (NCT00869232)
    Phase 2
    University of Arkansas
    Active, not recruiting
    Last update posted :
    08/09/2023
    Initiation :
    10/01/2008
    Primary completion :
    10/01/2024
    Completion :
    10/01/2024
    SDC1
    |
    cisplatin • bortezomib • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • thalidomide • melphalan • cyclophosphamide intravenous
    Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) (NCT02185820)
    Phase 1/2
    European Myeloma Network
    Completed
    Last update posted :
    06/30/2023
    Initiation :
    06/01/2014
    Primary completion :
    07/01/2015
    Completion :
    01/01/2023
    CRP
    |
    carfilzomib • dexamethasone • pomalidomide
    Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography (NCT02819024)
    Phase N/A
    Barbara Ann Karmanos Cancer Institute
    Active, not recruiting
    Last update posted :
    05/05/2023
    Initiation :
    06/01/2016
    Primary completion :
    11/08/2022
    Completion :
    11/01/2023
    NR3C1
    A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy (NCT00587067)
    Phase 2
    Memorial Sloan Kettering Cancer Center
    Completed
    Last update posted :
    04/04/2023
    Initiation :
    06/01/2003
    Primary completion :
    05/19/2016
    Completion :
    05/19/2016
    AFP
    |
    dexamethasone
    Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis (I-HEP) (NCT04810156)
    Phase 2
    Inge Marie Svane
    Recruiting
    Last update posted :
    12/14/2022
    Initiation :
    04/07/2021
    Primary completion :
    04/07/2025
    Completion :
    11/07/2025
    PD-L1
    |
    prednisone • methylprednisolone sodium succinate • prednisolone
    Vedolizumab for Immune Mediated Colitis (NCT04797325)
    Phase 2
    University of Copenhagen
    Recruiting
    Last update posted :
    08/17/2022
    Initiation :
    08/30/2021
    Primary completion :
    04/01/2025
    Completion :
    04/01/2025
    PD-L1
    |
    Entyvio (vedolizumab) • prednisolone
    Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT (KMM1911) (NCT05497102)
    Phase 2
    Samsung Medical Center
    Recruiting
    Last update posted :
    08/12/2022
    Initiation :
    11/08/2021
    Primary completion :
    05/01/2024
    Completion :
    12/01/2025
    CD34
    |
    lenalidomide • carfilzomib • dexamethasone • dexamethasone injection
    Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia (NCT04588857)
    Phase 4
    Rigshospitalet, Denmark
    Recruiting
    Last update posted :
    03/22/2022
    Initiation :
    03/01/2021
    Primary completion :
    12/01/2022
    Completion :
    06/01/2023
    CRP
    |
    dexamethasone injection
    Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone (NCT03375567)
    Phase N/A
    Yale University
    Completed
    Last update posted :
    02/24/2022
    Initiation :
    06/04/2018
    Primary completion :
    01/14/2022
    Completion :
    01/14/2022
    CD4
    |
    lenalidomide • carfilzomib • dexamethasone
    Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation (COVERAGE) (NCT04356495)
    Phase 2/3
    University Hospital, Bordeaux
    Completed
    Last update posted :
    02/04/2022
    Initiation :
    07/29/2020
    Primary completion :
    10/08/2021
    Completion :
    10/22/2021
    CD4
    Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) (NCT00075829)
    Phase 3
    National Heart, Lung, and Blood Institute (NHLBI)
    Completed
    Last update posted :
    11/01/2021
    Initiation :
    12/01/2003
    Primary completion :
    06/01/2012
    Completion :
    03/01/2013
    CD34
    |
    thalidomide
    Function and Composition of Regulatory B Cells in Participants With Glioblastoma (GBMdexaB) (NCT04128774)
    Phase N/A
    Amsterdam UMC, location VUmc
    Recruiting
    Last update posted :
    10/28/2021
    Initiation :
    01/01/2021
    Primary completion :
    11/01/2023
    Completion :
    11/01/2024
    IL2RA • ISG20
    |
    dexamethasone
    Reducing Dexamethasone Around Docetaxel Infusion (REDEX) (NCT02776436)
    Phase 1
    Leiden University Medical Center
    Active, not recruiting
    Last update posted :
    04/02/2021
    Initiation :
    01/01/2016
    Primary completion :
    11/20/2020
    Completion :
    05/01/2021
    IGF1
    |
    docetaxel • prednisone • dexamethasone
    Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients (NCT01402284)
    Phase 2
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    03/02/2021
    Initiation :
    07/21/2011
    Primary completion :
    07/10/2016
    Completion :
    09/24/2020
    SDC1
    |
    lenalidomide • carfilzomib • dexamethasone
    Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance (NCT01647165)
    Phase 2
    National Cancer Institute (NCI)
    Withdrawn
    Last update posted :
    12/12/2019
    Initiation :
    07/11/2012
    Primary completion :
    06/26/2015
    Completion :
    06/26/2015
    CD4
    |
    lenalidomide • bortezomib • dexamethasone
    Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer (NCT02520115)
    Phase 1
    Barbara Ann Karmanos Cancer Institute
    Completed
    Last update posted :
    08/14/2019
    Initiation :
    08/01/2015
    Primary completion :
    09/01/2018
    Completion :
    11/01/2018
    MUC16
    A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma (NCT01852799)
    Phase 2
    Shanghai Changzheng Hospital
    Completed
    Last update posted :
    08/10/2018
    Initiation :
    12/01/2012
    Primary completion :
    09/01/2016
    Completion :
    01/01/2017
    DKK1
    |
    bortezomib • doxorubicin hydrochloride • dexamethasone injection
    Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Treating Patients With Primary Liver Cancer That Cannot Be Removed By Surgery (NCT00310102)
    Phase 2
    Wake Forest University
    Completed
    Last update posted :
    08/04/2017
    Initiation :
    09/01/2004
    AFP
    |
    dexamethasone
    Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma (NCT00148317)
    Phase 2
    Weill Medical College of Cornell University
    Completed
    Last update posted :
    07/18/2017
    Initiation :
    06/01/2005
    Primary completion :
    02/01/2011
    Completion :
    11/01/2012
    CD34
    |
    bortezomib • cyclophosphamide • pegylated liposomal doxorubicin • Neupogen (filgrastim) • cyclophosphamide intravenous • doxorubicin liposomal
    SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone (NCT02928432)
    Phase 2
    Centro Nacional de Investigaciones Oncologicas ...
    Completed
    Last update posted :
    01/27/2017
    Initiation :
    06/01/2013
    Primary completion :
    09/01/2016
    Completion :
    01/01/2017
    AR
    |
    abiraterone acetate • prednisone • dexamethasone
    Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia (NCT01331590)
    Phase 1
    Washington University School of Medicine
    Completed
    Last update posted :
    09/20/2016
    Initiation :
    07/01/2011
    Primary completion :
    10/01/2014
    Completion :
    11/01/2015
    ABL1 • BCR
    |
    ifosfamide • etoposide IV • mesna • Neupogen (filgrastim)
    Tumor Gene Expression in Women With Ovarian Cancer (NCT00817479)
    Phase 4
    University of Chicago
    Completed
    Last update posted :
    07/13/2016
    Initiation :
    01/01/2003
    Primary completion :
    01/01/2013
    Completion :
    01/01/2013
    DUSP1
    |
    dexamethasone
    Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00010231)
    Phase 1
    University of Pittsburgh
    Completed
    Last update posted :
    03/30/2015
    Initiation :
    06/01/1999
    Primary completion :
    08/01/2002
    Completion :
    11/01/2002
    VDR
    |
    dexamethasone